XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Balance at beginning of period (in shares) at Dec. 31, 2022   385,000,000      
Balance at beginning of period at Dec. 31, 2022 $ 19,123 $ 0 $ 1,173 $ (370) $ 18,320
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted common stock (in shares)   1,000,000      
Exercise of options to purchase common stock (in shares)   3,000,000      
Exercise of options to purchase common stock 13   13    
Issuance of common stock under employee stock purchase plan 12   12    
Stock-based compensation 149   149    
Other comprehensive income (loss), net of tax 107     107  
Stock repurchased during period (in shares)   (8,000,000)      
Repurchase of common stock (1,154)   (1,154)    
Net loss (1,301)       (1,301)
Balance at end of period (in shares) at Jun. 30, 2023   381,000,000      
Balance at end of period at Jun. 30, 2023 16,949 $ 0 193 (263) 17,019
Balance at beginning of period (in shares) at Mar. 31, 2023   384,000,000      
Balance at beginning of period at Mar. 31, 2023 18,863 $ 0 731 (267) 18,399
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of options to purchase common stock (in shares)   1,000,000      
Exercise of options to purchase common stock 4   4    
Issuance of common stock under employee stock purchase plan 12   12    
Stock-based compensation 74   74    
Other comprehensive income (loss), net of tax 4     4  
Stock repurchased during period (in shares)   (4,000,000)      
Repurchase of common stock (628)   (628)    
Net loss (1,380)       (1,380)
Balance at end of period (in shares) at Jun. 30, 2023   381,000,000      
Balance at end of period at Jun. 30, 2023 $ 16,949 $ 0 193 (263) 17,019
Balance at beginning of period (in shares) at Dec. 31, 2023 382,000,000 382,000,000      
Balance at beginning of period at Dec. 31, 2023 $ 13,854 $ 0 371 (123) 13,606
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income (loss), net of tax 22        
Balance at end of period (in shares) at Mar. 31, 2024   383,000,000      
Balance at end of period at Mar. 31, 2024 $ 12,817 $ 0 487 (101) 12,431
Balance at beginning of period (in shares) at Dec. 31, 2023 382,000,000 382,000,000      
Balance at beginning of period at Dec. 31, 2023 $ 13,854 $ 0 371 (123) 13,606
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted common stock (in shares)   1,000,000      
Exercise of options to purchase common stock (in shares)   1,000,000      
Exercise of options to purchase common stock 37   37    
Issuance of common stock under employee stock purchase plan 10   10    
Stock-based compensation 213   213    
Other comprehensive income (loss), net of tax $ 52     52  
Stock repurchased during period (in shares) 0        
Net loss $ (2,454)       (2,454)
Balance at end of period (in shares) at Jun. 30, 2024 384,000,000 384,000,000      
Balance at end of period at Jun. 30, 2024 $ 11,712 $ 0 631 (71) 11,152
Balance at beginning of period (in shares) at Mar. 31, 2024   383,000,000      
Balance at beginning of period at Mar. 31, 2024 12,817 $ 0 487 (101) 12,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of options to purchase common stock (in shares)   1,000,000      
Exercise of options to purchase common stock 22   22    
Issuance of common stock under employee stock purchase plan 10   10    
Stock-based compensation 112   112    
Other comprehensive income (loss), net of tax $ 30     30  
Stock repurchased during period (in shares) 0        
Net loss $ (1,279)       (1,279)
Balance at end of period (in shares) at Jun. 30, 2024 384,000,000 384,000,000      
Balance at end of period at Jun. 30, 2024 $ 11,712 $ 0 $ 631 $ (71) $ 11,152